tislelizumab

CHEBI:CHEBI_751486

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
BULK INGREDIENT
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION, CONCENTRATE
active_ingredient_strength
10 mg/10mg
route
INTRAVENOUS
marketing_category
BULK INGREDIENT
marketing_start_date
20240314
package_marketing_start_date
01-MAY-23
labeler_name
Boehringer Ingelheim Biopharmaceuticals (China) Ltd.
manufacturer_name
BEIGENE USA, INC.
generic_name
tislelizumab
product_ndc
72579-121
spl_id
8b87c2d8-47ac-4c4f-8d74-4d45cbe4c3fe
active_ingredient_name
TISLELIZUMAB
package_ndc
72579-121-01
package_description
1 VIAL, GLASS in 1 CARTON (72579-121-01) / 10 mL in 1 VIAL, GLASS
nui
N0000191259
pharm_class_epc
Programmed Death Receptor-1 Blocking Antibody [EPC]
pharm_class_moa
Programmed Death Receptor-1-directed Antibody Interactions [MoA]
brand_name
TEVIMBRA
brand_name_base
TEVIMBRA
application_number
BLA761232
rxcui
2677439
unii
0KVO411B3N
spl_set_id
08ef1e3e-496f-4b0b-94ee-fbba3cc1985a
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class